Problems with the randomized discontinuation design

J Clin Oncol. 2006 Oct 1;24(28):4669-70; author reply 4670-1. doi: 10.1200/JCO.2006.08.1026.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Benzenesulfonates / pharmacology
  • Carcinoma, Renal Cell / drug therapy
  • Clinical Trials as Topic / methods*
  • Data Interpretation, Statistical*
  • Drug Administration Schedule*
  • Humans
  • Kidney Neoplasms / drug therapy
  • Niacinamide / analogs & derivatives
  • Phenylurea Compounds
  • Prognosis
  • Pyridines / pharmacology
  • Randomized Controlled Trials as Topic / methods*
  • Research Design*
  • Sorafenib
  • Survival Analysis
  • Treatment Outcome

Substances

  • Benzenesulfonates
  • Phenylurea Compounds
  • Pyridines
  • Niacinamide
  • Sorafenib